MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...
Oral GLP-1 RA peptide program clinical trial initiated Metsera has initiated a clinical trial ... and candidates targeting other complementary NuSH pathways, including glucagon and PYY, as well as ...
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of the ...
News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to their astronomical pricing, drug shortages, compounding disputes ...
Expert Rev Clin Pharmacol. 2013;6(2):171-183. Lifestyle Measures. Lifestyle measures – that is, physical activity and dietary measures, in some cases with concomitant behavioral modification ...